48
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      High-Dimensional Single-Cell Analysis Identifies Organ-Specific Signatures and Conserved NK Cell Subsets in Humans and Mice

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Summary

          Natural killer (NK) cells are innate lymphoid cells (ILCs) involved in antimicrobial and antitumoral responses. Several NK cell subsets have been reported in humans and mice, but their heterogeneity across organs and species remains poorly characterized. We assessed the diversity of human and mouse NK cells by single-cell RNA sequencing on thousands of individual cells isolated from spleen and blood. Unbiased transcriptional clustering revealed two distinct signatures differentiating between splenic and blood NK cells. This analysis at single-cell resolution identified three subpopulations in mouse spleen and four in human spleen, and two subsets each in mouse and human blood. A comparison of transcriptomic profiles within and between species highlighted the similarity of the two major subsets, NK1 and NK2, across organs and species. This unbiased approach provides insight into the biology of NK cells and establishes a rationale for the translation of mouse studies to human physiology and disease.

          Graphical Abstract

          Highlights

          • scRNA-seq on spleen and blood NK cells reveals organ-specific signatures

          • scRNA-seq reveals the heterogeneity of NK cells in the blood and spleen

          • scRNA-seq on NK cells defines NK1 as human CD56 dim and mouse CD27 CD11b + NK cells

          • scRNA-seq on NK cells defines NK2 as human CD56 bright and mouse CD27 +CD11b NK cells

          Abstract

          Several NK cell subsets have been reported in humans and mice, but their heterogeneity remains poorly characterized. Using high-throughput single-cell RNA-seq, Crinier et al. provide conserved tissue-specific gene signatures of NK cells from spleen and blood and identified two major NK cell subsets transcriptionally similar across organs and species.

          Related collections

          Most cited references19

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          NK Cells Stimulate Recruitment of cDC1 into the Tumor Microenvironment Promoting Cancer Immune Control

          Summary Conventional type 1 dendritic cells (cDC1) are critical for antitumor immunity, and their abundance within tumors is associated with immune-mediated rejection and the success of immunotherapy. Here, we show that cDC1 accumulation in mouse tumors often depends on natural killer (NK) cells that produce the cDC1 chemoattractants CCL5 and XCL1. Similarly, in human cancers, intratumoral CCL5, XCL1, and XCL2 transcripts closely correlate with gene signatures of both NK cells and cDC1 and are associated with increased overall patient survival. Notably, tumor production of prostaglandin E2 (PGE2) leads to evasion of the NK cell-cDC1 axis in part by impairing NK cell viability and chemokine production, as well as by causing downregulation of chemokine receptor expression in cDC1. Our findings reveal a cellular and molecular checkpoint for intratumoral cDC1 recruitment that is targeted by tumor-derived PGE2 for immune evasion and that could be exploited for cancer therapy.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Natural killer cells and other innate lymphoid cells in cancer

            Immuno-oncology is an emerging field that has revolutionized cancer treatment. Most immunomodulatory strategies focus on enhancing T cell responses, but there has been a recent surge of interest in harnessing the relatively underexplored natural killer (NK) cell compartment for therapeutic interventions. NK cells show cytotoxic activity against diverse tumour cell types, and some of the clinical approaches originally developed to increase T cell cytotoxicity may also activate NK cells. Moreover, increasing numbers of studies have identified novel methods for increasing NK cell antitumour immunity and expanding NK cell populations ex vivo, thereby paving the way for a new generation of anticancer immunotherapies. The role of other innate lymphoid cells (group 1 innate lymphoid cell (ILC1), ILC2 and ILC3 subsets) in tumours is also being actively explored. This Review provides an overview of the field and summarizes current immunotherapeutic approaches for solid tumours and haematological malignancies.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Transcriptional Programs Define Molecular Characteristics of Innate Lymphoid Cell Classes and Subsets

              The diversity of innate lymphoid cells (ILCs) is rapidly expanding. Three ILC classes have emerged, ILC1, ILC2, and ILC3, with ILC1 and ILC3 including several subsets. The classification of some subsets is unclear and it remains controversial whether NK cells and ILC1 are distinct cell types. To address these issues, we analyzed ILCs and NK cells gene expression within mouse small intestine, spleen, and liver, as part of the Immunological Genome Project. Results identify unique gene-expression patterns for some ILCs and overlapping patterns between ILC1 and NK cells, whereas few ILC subsets remain indistinguishable. A transcriptional program shared by small intestine ILCs and a core ILC signature is identified. Transcripts that suggest novel ILC functions and developmental paths are revealed and discussed.
                Bookmark

                Author and article information

                Contributors
                Journal
                Immunity
                Immunity
                Immunity
                Cell Press
                1074-7613
                1097-4180
                20 November 2018
                20 November 2018
                : 49
                : 5
                : 971-986.e5
                Affiliations
                [1 ]Aix Marseille Univ, CNRS, INSERM, Centre d’Immunologie de Marseille-Luminy, Marseille, France
                [2 ]Immunology, Marseille Immunopole, Hôpital de la Timone, Assistance Publique des Hôpitaux de Marseille, France
                [3 ]Innate Pharma Research Laboratories, Innate Pharma, Marseille, France
                [4 ]Internal Medicine, Hôpital de la Timone, Assistance Publique des Hôpitaux de Marseille, Marseille, France
                [5 ]General Surgery and Liver Transplantation, Hôpital de la Timone, Assistance Publique des Hôpitaux de Marseille, Marseille, France
                Author notes
                []Corresponding author vivier@ 123456ciml.univ-mrs.fr
                [6]

                These authors contributed equally

                [7]

                Lead Contact

                Article
                S1074-7613(18)30424-2
                10.1016/j.immuni.2018.09.009
                6269138
                30413361
                9fda099c-0a3a-4a3d-b92b-f64271f74b2f
                © 2018 The Authors

                This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

                History
                : 20 March 2017
                : 20 July 2018
                : 11 September 2018
                Categories
                Article

                Immunology
                nk cells,ilc,innate immunity,scrna-seq
                Immunology
                nk cells, ilc, innate immunity, scrna-seq

                Comments

                Comment on this article